MedTrace Logo

Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.

NCT02063113 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2023-05-23

No results posted yet for this study

Summary

The aim of this study is to determine whether the presence of vulnerability detected by geriatricians is associated with treatment discontinuation in older patient. During the comprehensive geriatric assessment realized before the decision-treatment, the following data are recorded and their impact in the therapeutic changes will also be analysed: comorbidity, age, depression, functional status, the cognitive impairment and malnutrition.

Conditions

  • Multiple Myeloma in Older Patients

Interventions

OTHER

Vulnerability and therapeutic changes in older patients with multiple myeloma.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Komivi AGBETSIVI, DR · CHD Vendée La Roche sur Yon

  • VIGNARD Patricia, Dr · CH du Mans

  • Catherine Cattenoz, Dr · Rennes University Hospital

  • Jean -Richard EVEILLARD, Dr · CHU de Brest

  • François Puisieux, Pr · CHU de Lille

  • Jean -Yves NIEMIER, Dr · Central Hospital, Nancy, France

  • Frédérique Retornaz, Dr · CGD de Marseille

  • Véronique Brunel, Dr · Hôpital Européen de Marseille

  • Laure De Decker, Dr · Nantes University Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-19
Primary Completion
2018-11-28
Completion
2018-11-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02063113 on ClinicalTrials.gov